Watsons Generic Product Approved

Published January 7, 2013

Watsons Generic Product Approved

Filed under: drug treatment programs in nyc

Watson Pharmaceuticals, Inc. (WPI – Analyst Report) recently announced that it gained US Food and Drug Administration (FDA) approval for its generic version of Ferring Pharmaceuticals' Lysteda (tranexamic acid) tablet. The company intends to launch the …
Read more on Zacks.com

Lorus Therapeutics Announces Successful Dose Escalation of Its Phase I …

Filed under: drug treatment programs in nyc

The success of this study allows Lorus to initiate a biomarker clinical investigation to further explore the effects of the drug at relevant doses determined in the clinical trial. This Phase I clinical study program, conducted at Memorial Sloan …
Read more on Marketwire (press release)

Dendreon's Provenge: New Opinion On Sequencing Agents Released

Filed under: drug treatment programs in nyc

One of the more important issues discussed among physicians and investors alike when it comes to Dendreon (DNDN) in general and Provenge in particular is the sequencing of this immunotherapeutic treatment with other agents. Critics of the corporation …
Read more on Seeking Alpha